Attenzione! Per visualizzare al meglio il sito e usufruire di tutte le funzionalità messe a disposizione
si consiglia di aggiornare la versione in uso di Internet Explorer alla versione 8 o superiore. Grazie!

La rete delle conoscenze nefrologiche

Home > Nefrologo in Corsia

Pubblicato il 25 giugno 2013

Tossicità renale e cerebrale acuta da litio: sindrome cerebro-renale? Descrizione di un caso clinico

Tossicità renale e cerebrale acuta da litio:sindrome cerebro-renale? Descrizione di un caso clinico

The Acute Renal and Cerebral Toxicity of Lithium: a Cerebro-renal Syndrome? A Case Report

M Prencipe1, A Cicchella1, A Del Giudice1, A Di Giorgio2, A Scarlatella1, M Vergura1, F Aucella1

(1) Unità operativa di Nefrologia e Dialisi Ospedale Casa Sollievo della Sofferenza IRCCS, San Giovanni Rotondo
(2) Servizio di Psicologia clinica Ospedale Casa Sollievo della Sofferenza IRCCS, San Giovanni Rotondo

Corrispondenza a: Michele Prencipe; Dirigente Nefrologo presso Ospedale "Casa Sollievo della Sofferenza", IRCCS; Viale Cappuccini, 71013 San Giovanni Rotondo (Foggia); Tel 0882 410399, fax 0882 410208, U.O. Nefrologia e Dialisi; mail: mikprenc@libero.it

Abstract

This descriptive report describes the case of a 50 year-old woman with bipolar disorder, whose maintenance therapy comprised risperidone, sodium valproato and lithium carbonate without any past occurrence of toxicity. Her past medical history was significant for hypertension, cardiopathy and obesity. She presented with a 1-week history of fever, increasing confusion and slurred speech. At presentation, the patient was somnolent. Laboratory investigations revealed a serum creatinine of 3,6 mg/dl, BUN 45 mg/dl serum lithium 3,0 mEq/L with polyuria defined as more than 3 litres a day.  EEG and ECG were abnormal. CT brain scanning and lumbar puncture were negative for brain haemorrage or infection. Lithium toxicity causes impairment of renal concentration and encephalopathy due to lithium recirculation, a mechanism responsible for the so-called cerebro-renal syndrome, where dialysis plays an important role in treatment.The patient was treated with continous veno-venous haemodiafiltration (CVVHDF) over 35 hours with gradual improvement of her general condition and efficacy of renal concentration. Our case highlights a few important points. Lithium nefrotoxicity and neurotoxicity can cause a cerebro-renal syndrome even when serum lithium levels are not particularly raised (2,5-3,5 mEq/L). Haemodialysis is the treatment of choice to reduce the molecular mechanisms of lithium-related changes in urinary concentration and reinstate dopaminergic activity in the brain.

BibliografiaReferences

[1] McKnight RF, Adida M, Budge K et al. Lithium toxicity profile: a systematic review and meta-analysis. Lancet 2012 Feb 25;379(9817):721-8

[2] Goodwin FK, Fireman B, Simon GE et al. Suicide risk in bipolar disorder during treatment with lithium and divalproex. JAMA : the journal of the American Medical Association 2003 Sep 17;290(11):1467-73

[3] Baldessarini RJ, Tondo L, Davis P et al. Decreased risk of suicides and attempts during long-term lithium treatment: a meta-analytic review. Bipolar disorders 2006 Oct;8(5 Pt 2):625-39

[4] Finley PR, Warner MD, Peabody CA et al. Clinical relevance of drug interactions with lithium. Clinical pharmacokinetics 1995 Sep;29(3):172-91

[5] Smith SJ, Kocen RS A Creutzfeldt-Jakob like syndrome due to lithium toxicity. Journal of neurology, neurosurgery, and psychiatry 1988 Jan;51(1):120-3 (full text)

[6] Noveske FG, Hahn KR, Flynn RJ et al. Possible toxicity of combined fluoxetine and lithium. The American journal of psychiatry 1989 Nov;146(11):1515

[7] S.C. Mann,S.N. Caroff,G. Fricchione,and E. C. Campbell.central dopamine hypoactivity and pathogenesis of neuroleptic malignant syndrome.Psychiatric Annals 2000;vol 30,pp363-374.

[8] Nisijima K, Ishiguro T Cerebrospinal fluid levels of monoamine metabolites and gamma-aminobutyric acid in neuroleptic malignant syndrome. Journal of psychiatric research 1995 May-Jun;29(3):233-44

[9] Gould TD, Quiroz JA, Singh J et al. Emerging experimental therapeutics for bipolar disorder: insights from the molecular and cellular actions of current mood stabilizers. Molecular psychiatry 2004 Aug;9(8):734-55

[10] Wallin L, Alling C, Aurell M et al. Impairment of renal function in patients on long-term lithium treatment. Clinical nephrology 1982 Jul;18(1):23-8

[11] Marples D, Christensen S, Christensen EI et al. Lithium-induced downregulation of aquaporin-2 water channel expression in rat kidney medulla. The Journal of clinical investigation 1995 Apr;95(4):1838-45

[12] Christensen BM, Kim YH, Kwon TH et al. Lithium treatment induces a marked proliferation of primarily principal cells in rat kidney inner medullary collecting duct. American journal of physiology. Renal physiology 2006 Jul;291(1):F39-48 (full text)

[13] Corman B, Roinel N, de Rouffignac C et al. Dependence of water movement on sodium transport in kidney proximal tubule: a microperfusion study substituting lithium for sodium. The Journal of membrane biology 1981;62(1-2):105-11

[14] Farres MT, Ronco P, Saadoun D et al. Chronic lithium nephropathy: MR imaging for diagnosis. Radiology 2003 Nov;229(2):570-4 (full text)

[15] Batlle DC, von Riotte AB, Gaviria M et al. Amelioration of polyuria by amiloride in patients receiving long-term lithium therapy. The New England journal of medicine 1985 Feb 14;312(7):408-14

[16] Bedford JJ, Weggery S, Ellis G et al. Lithium-induced nephrogenic diabetes insipidus: renal effects of amiloride. Clinical journal of the American Society of Nephrology : CJASN 2008 Sep;3(5):1324-31 (full text)

[17] Allen HM, Jackson RL, Winchester MD et al. Indomethacin in the treatment of lithium-induced nephrogenic diabetes insipidus. Archives of internal medicine 1989 May;149(5):1123-6

[18] Lithium.In: Ellenhorn MJ, Schonwald S, Ordog G, Wasserberger J editors.Medical toxicology:diagnosis and treatment of Human poisoning.Baltimore:Williams and Wilkins 1997; 1579.

[19] Winchester JF,Boldur A,Oleu C,Kitiyarakara C.Use of dialysis and hemoperfusion in treatment of poisoning.In Daugirdas JT.Ed Hndbook of Dialysis 4 th ed. 2007;Philadelphia:Walters Kluwer 300-319

[20] Holubek WJ, Hoffman RS, Goldfarb DS et al. Use of hemodialysis and hemoperfusion in poisoned patients. Kidney international 2008 Nov;74(10):1327-34

Per visualizzare l'intero documento devi essere registrato e aver eseguito la con utente e password.

Versione PDF
Per visualizzare l'intero documento devi essere registrato e aver eseguito la con utente e password.
Contenuti articolo
    release  1
    pubblicata il  25 giugno 2013 
    Da

    M Prencipe1, A Cicchella1, A Del Giudice1, A Di Giorgio2, A Scarlatella1, M Vergura1, F Aucella1

    (1) Unità operativa di Nefrologia e Dialisi Ospedale Casa Sollievo della Sofferenza IRCCS, San Giovanni Rotondo
    (2) Servizio di Psicologia clinica Ospedale Casa Sollievo della Sofferenza IRCCS, San Giovanni Rotondo

    Corrispondenza a: Michele Prencipe; Dirigente Nefrologo presso Ospedale "Casa Sollievo della Sofferenza", IRCCS; Viale Cappuccini, 71013 San Giovanni Rotondo (Foggia); Tel 0882 410399, fax 0882 410208, U.O. Nefrologia e Dialisi; mail: mikprenc@libero.it

    Parole chiave: litio
    Non ci sono commenti
    Figure


    Editor in chief
    dr. Biagio Raffaele Di Iorio
    Co-redattori
    dr.ssa Cristiana Rollino
    dr. Gaetano La Manna
    Redattori associati
    dr. Alessandro Amore
    dr. Antonio Bellasi
    dr. Pino Quintaliani
    dr. Giusto Viglino
    Direttore responsabile
    Fabrizio Vallari
    Segreteria
    gin_segreteria@sin-italy.org
    fax 0825 530360

    © 2013-2024 Società Italiana di Nefrologia — ISSN 1724-5990 — Editore Tesi SpA

    Giornale Italiano di Nefrologia è una testata giornalistica registrata presso il Tribunale di Milano. Autorizzazione n. 396 del 10.12.2013.

    La piattaforma web su cui condividere in maniera semplice, efficace ed interattiva le conoscenze nefrologiche attraverso la pubblicazione online di documenti multimediali.

    INFORMATIVA

    NephroMEET accoglie come documenti con marchio SIN quelli approvati da: Comitati e Commissioni ufficiali SIN, Gruppi di Studio SIN, Sezioni Regionali/Interregionali SIN.

    Il Consiglio Direttivo SIN si riserva inoltre la facoltà di certificare con marchio SIN altri documenti qualora lo ritenga opportuno.

    Gli Autori si assumono in ogni caso la responsabilità dei contenuti pubblicati.

    I contenuti pubblicati sono riservati ad un pubblico esperto nel settore medico-scientifico.

    Seguici su Twitter

    Developer e partner tecnologico:
    TESISQUARE®

    Assistenza telefonica allo 0172 476301
    o via mail

    Cookie Policy